Abstract
An isolate of Klebsiella oxytoca carrying a novel IMP metallo-β- lactamase was discovered in Madrid, Spain. The blaIMP-28 gene is part of a chromosomally located class I integron. The IMP-28 kcat/K m values for ampicillin, ceftazidime, and cefepime and, to a lesser extent, imipenem and meropenem, are clearly lower than those of IMP-1. The His306Gln mutation may induce important modifications of the L3 loop and thus of substrate accessibility and hydrolysis and be the main reason for this behavior. Copyright © 2012, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Pérez-Llarena, F. J., Fernández, A., Zamorano, L., Kerff, F., Beceiro, A., Aracil, B., … Bou, G. (2012). Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate. Antimicrobial Agents and Chemotherapy, 56(8), 4540–4543. https://doi.org/10.1128/AAC.00776-12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.